Paper40985304
A Hypoxia-Responsive Single-Atom Sonozyme for Targeted Sonocatalytic Therapy in Alleviating Atherosclerotic Plaque.
Chen Q and 14 others. Adv Sci (Weinh), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. A Hypoxia-Responsive Single-Atom Sonozyme for Targeted Sonocatalytic Therapy in Alleviating Atherosclerotic Plaque. Papers, record 40985304. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40985304
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Hypoxia-Responsive Single-Atom Sonozyme for Targeted Sonocatalytic Therapy in Alleviating Atherosclerotic Plaque.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plaque, Atherosclerotic | Major topic |
| Ultrasonic Therapy | Major topic |
| Atherosclerosis | Major topic |
| Hypoxia | Major topic |
| Animals | |
| Mice | |
| Disease Models, Animal | |
| Catalysis | |
| Hyaluronic Acid | |
| Macrophages | |
| Mice, Inbred C57BL | |
| Manganese |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82400397 | National Natural Science Foundation of China | PubMed | ||
| 2023A1515110251 | Guangdong Basic and Applied Basic Research Foundation | PubMed | ||
| 2023A1515220122 | Guangdong Basic and Applied Basic Research Foundation | PubMed | ||
| 2023B1515120073 | Guangdong Basic and Applied Basic Research Foundation | PubMed | ||
| 2024A04J4680 | Science and Technology Projects in Guangzhou | PubMed | ||
| 2025B01J3013 | Science and Technology Projects in Guangzhou | PubMed | ||
| 2025A03J4426 | The Guangzhou Science and Technology Bureau | PubMed | ||
| JCYJ20230807154402004 | The Shenzhen Research Funding Program | PubMed | ||
| LGKCYLWS2023005 | The Shenzhen Innovation of Science and Technology Commission | PubMed |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34623330 | HIF in the heart: development, metabolism, ischemia, and atherosclerosis. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34623330 | PubMed |
| 2 | 18371555 | Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. | J Am Coll Cardiol | 2008 | https://conductscience.org/library/papers/18371555 | PubMed |
| 3 | 33898179 | Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/33898179 | PubMed |
| 4 | 32191455 | Ultrafine Titanium Monoxide (TiO1+x) Nanorods for Enhanced Sonodynamic Therapy. | J Am Chem Soc | 2020 | https://conductscience.org/library/papers/32191455 | PubMed |
| 5 | 40985304 | A Hypoxia-Responsive Single-Atom Sonozyme for Targeted Sonocatalytic Therapy in Alleviating Atherosclerotic Plaque. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40985304 | PubMed |
| 6 | 27444197 | Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis. | Arterioscler Thromb Vasc Biol | 2016 | https://conductscience.org/library/papers/27444197 | PubMed |
| 7 | 37698552 | Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug Formulations. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37698552 | PubMed |
| 8 | 31618541 | Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31618541 | PubMed |
| 9 | 26297351 | Atherosclerosis, neoatherosclerosis, and vascular disease. | Eur Heart J | 2015 | https://conductscience.org/library/papers/26297351 | PubMed |
| 10 | 32043020 | Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis. | JACC Basic Transl Sci | 2020 | https://conductscience.org/library/papers/32043020 | PubMed |
| 11 | 37438560 | Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. | Nat Rev Mol Cell Biol | 2023 | https://conductscience.org/library/papers/37438560 | PubMed |
| 12 | 27667687 | Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages. | Cell | 2016 | https://conductscience.org/library/papers/27667687 | PubMed |
| 13 | 38244055 | Macrophage profiling in atherosclerosis: understanding the unstable plaque. | Basic Res Cardiol | 2024 | https://conductscience.org/library/papers/38244055 | PubMed |
| 14 | 23818780 | Apoptosis of THP-1 macrophages induced by protoporphyrin IX-mediated sonodynamic therapy. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23818780 | PubMed |
| 15 | 37480922 | 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. | J Am Coll Cardiol | 2023 | https://conductscience.org/library/papers/37480922 | PubMed |
| 16 | 34153348 | Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. | J Vasc Surg | 2022 | https://conductscience.org/library/papers/34153348 | PubMed |
| 17 | 38799235 | Sonodynamic therapy for the treatment of atherosclerosis. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/38799235 | PubMed |
| 18 | 38898135 | Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment. | Nat Nanotechnol | 2024 | https://conductscience.org/library/papers/38898135 | PubMed |
| 19 | 23509769 | The sonodynamic effect of curcumin on THP-1 cell-derived macrophages. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23509769 | PubMed |
| 20 | 32144406 | Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32144406 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42600335 | Advances in ultrasound-mediated nanozyme systems in therapeutic applications. | Ultrason Sonochem | 2026 | https://conductscience.org/library/papers/42600335 | PubMed |
| 40985304 | A Hypoxia-Responsive Single-Atom Sonozyme for Targeted Sonocatalytic Therapy in Alleviating Atherosclerotic Plaque. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40985304 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40985304
GET https://conductscience.org/api/papers/v1/40985304/references?page=2